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Antichymotrypsin (SERPINA3) is a widely expressed member of the serpin superfamily, required for the regulation of leukocyte proteases released during an inflammatory response and with a permissive role in the development of amyloid encephalopathy. In spite of its biological significance, there is at present no available structure of this serpin in its native, inhibitory state. We present here the first fully refined structure of a murine antichymotrypsin orthologue to 2.1 Å, which we propose as a template for other antichymotrypsin-like serpins.
A most unexpected feature of the structure of murine serpina3n is that it reveals the reactive centre loop (RCL) to be partially inserted into the A β-sheet, a structural motif associated with ligand dependent activation in other serpins. The RCL is, in addition, stabilised by salt bridges and its plane is oriented at 90 degrees to the RCL of antitrypsin. A biochemical and biophysical analysis of this serpin demonstrates that it is a fast and efficient inhibitor of human leukocyte elastase (k a : 4 ± 0.9 x 10 6 M -1 sec -1) and cathepsin G (k a : 7.9 ± 0.9 x 10 5 M -1 sec -1) giving a spectrum of activity intermediate between that of human antichymotrypsin and human antitrypsin. An evolutionary analysis reveals that residues subject to positive selection and which have contributed to the diversity of sequences in this sub-branch (A3) of the serpin superfamily are essentially restricted to the P 4 -P 6 ' region of the RCL, the distal hinge and the loop between strands 4B and 5B. . α 1 -antichymotrypsin (SERPINA3) is a member of the serpin superfamily of protease inhibitors.
Like its close orthologue α 1 -antitrypsin, it was first characterised as an acute phase plasma protease inhibitor (1) , and is synthesised in a range of tissues including hepatocytes (2) , bronchial epithelial cells (3) and neuronal cells (4) . In the lung, α 1 -antichymotrypsin (referred to as huACT hereafter) plays an important role in the regulation of proteases released by leukocytes during an inflammatory response (5) , cathepsin G (Cat G) (5) and mast cell chymase (6) . In the brain, huACT has been identified in amyloid plaques (7) and its over-expression plays a permissive role in the progression of Alzheimer's disease (8) and cerebral amyloid encephalopathy (9) . Current evidence suggests that its role in the brain, and consequently the basis of its association with amyloid plaques, is as a component of the inflammatory response (10) . Serpins are the largest family of protease inhibitors and extend to all branches of life (11, 12) . Members of this class of protein perform roles in diverse physiological processes such as the blood clotting cascade, apoptosis and chromatin condensation (13) . The serpin fold is highly conserved and consists of 3 β-sheets, 8-9 α-helices and a solvent exposed stretch of amino acids termed the reactive centre loop (RCL) (14) . The mechanism of inhibition has been demonstrated biophysically and structurally. Serpins "hijack" the proteolytic mechanism, during which a protease and substrate are transiently linked by an acyl ester bond. The cognate protease binds to, and cleaves within, specificity-determining residues of the RCL; following cleavage of the peptide bond, the RCL is thermodynamically driven to insert into the centre of the A β-sheet, the tethered protease translocates ~70 Å and becomes compressed against the base of the serpin. Distortion of the active site prevents the final hydrolysis event and the result is an irreversible, covalent serpinenzyme complex (15) .
The ability of serpins to accommodate a nascent RCL confers an important vulnerability: the propensity to form long-chain polymers in which the RCL of one molecule becomes embedded in the A β-sheet (or the C β-sheet) of the next (16, 17) . This state can be brought about by point mutation. For example, the Pro229Ala mutation renders huACT susceptible to polymerisation: the protein is deposited as inclusions in hepatocytes leading to liver damage and the resulting deficiency in the lungs results in obstructive pulmonary disease (18) . Similarly, the Leu55Pro mutation destabilises the serpin, leading to the formation of polymers and the inactive, monomeric "latent" form (19) .
In rats and mice the antichymotrypsin gene has undergone extensive duplication and diversification (20) , yielding a family of 13 closely-related inhibitors within the murine serpina3 cluster with differing tissue distribution and protease specificity (21, 22) . A similar event has also occurred at some other serpin loci including antitrypsin (23) and MNEI, PI-6 and PI-9 (24), and has been observed for numerous genes throughout the mouse and rat genomes (25) . Gene expression studies suggest that serpina3n (also known as EB22.4 and referred to here as muACT-n) is the closest murine orthologue of huACT. In particular, it is the only member of the serpina3 cluster that is expressed in the murine brain under resting conditions (21) , consistent with evidence that huACT plays a role in the inflammatory response in that organ. As with huACT, muACT-n demonstrates a wide tissue distribution: it is found in the liver, brain, testis, lung, thymus, spleen, and to a lesser extent bone marrow, skeletal muscle, and kidney (21) .
As muACT-n is a likely orthologue of huACT, we sought to characterise this protein both structurally and kinetically. We demonstrate that muACT-n is expressed as a functional, inhibitory serpin and possesses activity that bridges the specificities of both huACT and huAT. The structure of this serpin reveals that the RCL is partially inserted into the A β-sheet, is tilted almost 90 degrees with respect to human antitrypsin (huAT) and antithrombin, and is stabilised by two salt bridges tethering it to the body of the serpin. The positively-charged residues involved in DNA-binding in huACT were also found to be solvent exposed in muACT-n, and contribute to one of two patches of positive charge (near the s3C-s4C loop and on the F-helix) on one face of the serpin.
These data provide a framework for developing a further understanding of the role of the murine a3 serpins in the biology of their host.
(Melbourne, Australia). Bovine chymotrypsin and trypsin were purchased from Sigma-Aldrich (Sydney, Australia). Human leukocyte elastase (HLE) and human leukocyte Cat G were obtained from Athens Research Technology (Athens, USA). Unless otherwise stated general chemicals were purchased from Sigma (Sydney, Australia) and chromatographic equipment from Bio-Rad (California, USA). Colorimetric assays were performed using a Thermomax microplate reader from Molecular Devices (California, USA).
Production of recombinant muACT-n -Mouse brain was isolated from 7 week NMRI mice, and RNA extracted using the acidguanidinium/phenol/chloroform method (26) . 2 µg of total RNA was reverse transcribed with Superscript II reverse transcriptase and 5 pmol/L oligo(dT). For expression of muACT-n, the sense primer was designed to exclude the predicted Nterminal secretion peptide. Primers introducing BamHI restriction site tails for cloning into the pET-His(3a) expression vector were as follows: sense (5'-ATGGATCCTTCCCAGATGGCAC-3') and antisense (5'-ATGGATCCTCATTTGGGGTTGGCT-3'). The muACT-n was subcloned into the BamHI restriction site of the pET-His(3a) expression vector to produce a N-terminal His-tagged protein.
Correct orientation and sequence were confirmed by DNA sequencing. The construct was then used to transform BL21 (DE3) pLysS cells and recombinant protein production induced with 0.2 mM IPTG (final concentration) during the mid-log growth phase for 2 hrs. Cells were harvested by centrifugation (1,500 x g) and resuspended in lysis buffer [50 mM sodium phosphate pH 7.8, 100 mM NaCl, 10 mM imidazole] to which 1 mg/ml lysozyme, 20 µg/mL PMSF, protease inhibitor cocktail (1/1000) and 5 mM 2-β-mercaptoethanol was added. The lysate was incubated on ice for 30 mins and 25 ug/mL DNase was added. The cells were freeze/thawed 3 times in liquid N 2 and a 37°C water bath, respectively. Soluble protein was bound to Ni-NTA agarose (Qiagen), eluted with a 0.125 M imidazole step gradient and further purified using a Mono Q column (Amersham) with a 0-0.5 M NaCl gradient in 20 mM Tris, pH 8.0, 0.1 mM EDTA and 5 mM 2-β-mercaptoethanol.
Digestion of muACT-n by trypsin -To generate RCL cleaved serpin, 1 mg of muACT-n was incubated with trypsin at 20:1 (w:w) at 37°C for 2 hr. The reactions were stopped by the addition of PMSF to a final concentration of 20 µg/mL and samples placed on ice. Cleaved proteins were purified on a MonoQ column to remove traces of protease.
Circular dichroism -CD analysis was performed on a Jasco 820s spectropolarimeter (Jasco, Easton, USA). Changes in protein secondary structure were monitored by measuring the change in ellipticity at 222 nm using a 0.05 cm path-length cuvette and a protein concentration of 0.2 mg/ml in phosphate buffered saline, pH 7.4. Thermal unfolding experiments were performed by heating at a rate of 1°C/min from 25-90°C.
Complex formation assays -The ability of muACT-n to inhibit the serine proteases bovine chymotrypsin and trypsin, Cat G, HLE, human plasma thrombin and factor Xa was investigated by SDS-PAGE. 1 µM of each serine protease was incubated with either 1 µM or 5 µM muACT-n in 1xPBS. Reactions were incubated at 37°C for 30 min, then immediately placed on ice and SDS-PAGE reducing buffer was added. Samples were denatured at 95°C for 5 min, separated on 10% reducing SDS-PAGE and transferred to PVDF by Western blotting. Membranes were probed with mouse-His-antibody (1/2000) and goat-anti-mouse-HRP (1/5000). Proteins were detected with ECL reagent and visualised by autoradiography.
Stoichiometry of inhibition -Stoichiometry of inhibition (SI) values were determined for the interaction between with chymotrypsin, Cat G or HLE and muACT-n. muACT-n (0.5 nM-4 nM) was incubated with a constant concentration of chymotrypsin (2 nM) at 37°C for 4 hrs and residual activity assayed with the substrate N-succinyl-Ala-Ala-Pro-Phe-pNA (100 µM). Inhibition of Cat G (30 nM) was titrated with increasing concentrations of muACT-n (7.5-60 nM) at room temperature for 2 hrs and residual activity assayed with the substrate N-succinyl-AlaAla-Pro-Phe-pNA (500µM) on BSA coated microtitre plates. HLE (2 nM) was incubated with increasing concentrations of muACT-n (0.5-4 nM) at 37°C for 2 hrs and assayed with 200 µM N-methoxy-Ala-Ala-Pro-Val-pNA on BSA coated microtitre plates. Following linear regression analysis of the plot of residual enzyme activity against serpin concentration, the SI was determined by extrapolating to the protease:serpin ratio where protease activity is zero. The SI values represent the average of three separate experiments.
Association rate constant (continuous method) -
Rate constants were measured under pseudo-first order conditions using the progress-curve method (27) for the interaction of muACT-n with HLE and Cat G. For HLE, assays were carried out using 0.4 nM HLE, 0.4-2.8 nM muACT-n and 200 µM N-methoxy-Ala-Ala-Pro-Val-pNA at 37°C in BSA coated microtitre plates. For cat G, assays were performed with 20 nM cat G, 4-40 nM muACT-n and 1 mM N-succinyl-Ala-Ala-Pro-Phe-pNA at room temperature in BSA coated microtitre plates. A constant amount of protease was mixed with varying amounts of muACT-n and substrate, with the rate of product formation (measured at OD 405nm ) described by Equation 1 where P is the concentration of product at time t, k obs is the apparent first-order rate constant and v o is the initial velocity (28):
For each inhibitor concentration [I], a k obs value was calculated by non-linear least-squares fitting of the data to Equation 1. The resulting k obs values were plotted against [I] , and the uncorrected second-order rate constant (k') determined from the slope of the line of best fit; k' was corrected for substrate concentration [S], the K M of the protease and SI yielding the second-order rate constant, k a (equation 2):
The k a values for the inhibition of cat G and HLE represent the average of two and three separate experiments, respectively. Regression analysis was performed using Graphpad Prism 3 (Graphpad Software, CA, USA).
Association rate constant (discontinuous method) -
A discontinuous method (29) was used to determine the rate of inhibition (k a ) of chymotrypsin by muACT-n. The pseudo-first order rate constant with chymotrypsin (2 nM) and muACT-n (10-100 nM) was determined by incubation for different periods of time (0-5 min) followed by measurement of residual chymotrypsin activity. The pseudo-first order constant, k obs , was determined from the slope of a semi-log plot of the residual protease activity against time. The k obs values were then plotted against serpin concentration and the slope of the line of best fit gave an estimate of the secondorder rate constant, k a . The k a values represent the average of three separate experiments.
Crystallization of muACT-n -Crystallization trials were undertaken using the hanging drop vapour diffusion technique, employing a 1 µl:1 µl drop ratio of muACT-n (at 15 mg/ml) to mother liquor, with a 0.5-1 ml reservoir volume at 22°C. Single large crystals grew in 24% PEG 3350, 0.1 M sodium tartrate, 0.1 M HEPES pH 6.6 after 2 weeks. The crystals were flash-cryocooled prior to data collection with 15% glycerol as the cryoprotectant.
X-ray data collection, structure determination and refinement -Out of several crystals screened, one diffracted to 2.1 Å resolution; integration and scaling using the HKL suite (30) revealed it belonged to space group P2 1 2 1 2 1 , with unit cell dimensions of a = 83.34 Å, b = 92.62 Å, c = 118.26 Å. This is consistent with two monomers in the asymmetric unit and approximately 52% solvent content as predicted using the CCP4 program Matthews (31). Table 1 presents a summary of data collection statistics.
The structure of muACT-n was solved using the molecular replacement method (resolution range 10 to 3.5 Å) implemented within the MOLREP program (32) . The structure of human native huAT (pdb accession, 1QLP) proved to be superior as a search model to cleaved huACT (pdb accession, 1AS4), providing tentative evidence that the molecules within the crystal corresponded more closely with the native conformation.
In both search models, the sequence differences had been mutated to alanine. A single peak in rotation and two strong peaks in the translation function revealed two molecules separated by an orthogonal pseudo-translation of (49.7 Å, -2.5 Å, 2.9 Å). The molecules packed well within the unit cell and the resulting initial electron density map revealed strong unbiased features, particularly in the region of the RCL, suggesting the molecular replacement had been successful.
The progress of refinement (using data between 2.1 Å-30 Å) was monitored by the R free value without a sigma cut-off applied to the data. The structure was refined in CNS version 1.1 (33) using successive rounds of: (1) rigid-body fitting of the individual domains; (2) imposition of strict non-crystallographic symmetry constraints during simulated annealing and individual B-factor refinement; and (3) manual model building using the program O (34). Bulk solvent corrections were applied throughout. Once the R free value dropped below ~35%, the two molecules were treated separately with medium NCS positional (150/Å 2 ) and B-factor (2.5σ) restraints on residues not involved in crystal or NCS contacts. Refinement proceeded with rounds of (1) maximum-likelihood minimisation, (2) B-factor refinement and (3) model building.
Water molecules were manually built into the model if they were within hydrogen-bonding distance to chemically reasonable groups, if they appeared in F o -F c maps contoured at 3.0σ, and subsequently generated 2F o -F c maps contoured at 1.0σ. The two final rounds of refinement were undertaken with REFMAC5 (35), using default medium mainchain and loose side-chain NCS restraints, individual isotropic B-factors, Babinet solvent scaling and translation libration screw (TLS) refinement. Residue numbering is that of the precursor protein, with the start codon methionine at position 1 Structural Analysis -Hydrogen bonds and salt bridges were calculated using HBPLUS (36), surface area using DSSP (37) , and superpositions conducted using LSQMAN (38) . MolScript (39), Bobscript (40) and Raster3D (41) were used to produce structure cartoons, GRASP (42) to produce surface potential maps and Alscript (43) to produce the alignment figure. Crystal contacts (cutoff 3.5Angstrom, replace with SYMBOL) were calculated using the WHATIF server (44) .
Sequence analysis -Antitrypsin and antichymotrypsin-like protein sequences were identified from human, cow, pig and rat using the BLAST algorithm (45) and muACT-n as a probe with an expect threshold of 1x10 -6 and minimum sequence identity of 35%; mouse sequences were those described previously (21) .
Following construction of an initial set of 500 distance neighbour-joining bootstrapped distance trees using MOLPHY (46) , sequences showing a strong association with muACT-n were short-listed using the partition consensus method (11, 47) . A multiple protein alignment was performed using CLUSTALW (48) and patterns of divergence across sites within these sequences were examined using maximum likelihood dN/dS determination (49) . Nucleotide sequences were obtained and 'threaded', codon-by-codon, onto the protein alignment.
Phylogenetic analysis -The resulting alignments were used within MEGA3 (50) to obtain bootstrapped (1000 replicates), neighbour-joined phylogenetic trees using (a) protein distances computed using the JTT matrix; (b) nucleotide distances using the Kimura 2-parameter approach; (c) non-synonymous distances estimated using the Kumar method. While (b) failed to resolve the branching arrangement satisfactorily, (a) and (c) yielded essentially identical, fairly well-resolved trees. The consensus tree (with branches collapsed where they had less than 70% bootstrap support) was used to examine sequence evolution at the codon level with the CODEML program (51). This software uses maximum likelihood criteria to infer the rate of evolution at a site in the alignment, defined as the ratio of non-synonymous (amino acid-changing) mutations to synonymous (non-amino acid-changing) mutations (or dN/dS ratio) at the nucleotide level. A ratio significantly larger than 1 indicates the site is undergoing positive (adaptive) selection, and a ratio significantly lower than 1 indicates that the site is under negative (purifying) selection. To avoid overfitting of the data with a limited number of sequences, the average dN/dS ratio was held constant for all branches in the tree, but allowed to vary across the alignment, with sites subject to positive selection predicted using the 3-rate discrete categories option. This determines the probability of each column in the alignment being subject to negative selection (refined average dN/dS=0.13), no selection (dN/dS=0.81), and positive selection (dN/dS=3.3). Sites (codon positions) determined on the balance of probability to be under positive selection were recorded. The same program permitted ancestral amino acid sequences (those at the nodes of the tree) to be predicted from the amino acid sequence data (Poisson model of amino acid substitution, with the average dN/dS ratio held constant between branches).
RESULTS
Recombinant muACT-n is in the native conformation -The nucleotide sequence of the muACT-n cDNA isolated from mouse brain agreed with the published sequence (Accession No: M64086.1), except for Lys(70)→Thr, Val(85)→Leu, Met(86)→Val and Cys(231) →Ala. These variations are conserved with other members of the mouse serpina3 cluster and are unlikely to affect the structural or functional properties of the protein. Figure 1a shows the RCL residues of muACT-n in comparison to its human counterparts, huACT and huAT. The proximal hinge residues of muACT-n are typical of inhibitory serpins (52) , suggesting that muACT-n should undergo the conformational change required for protease inhibition.
To assess whether muACT-n had the biophysical characteristics of an inhibitory serpin, CD analysis during thermal denaturation was performed. Figure 1b shows that muACT-n underwent an unfolding transition typical of a serpin in its native conformation (53) , with a melting point of 61.5°C ± 0.74. Cleavage of the RCL causes an inhibitory serpin to undergo a substantial conformational change, leading to a marked increase in thermostability. Analysis of RCL cleaved muACT-n by CD thermal denaturation demonstrated loss of the unfolding transition indicative of reactive centre loop insertion into the serpin A-beta sheet (Figure 1b) . These results were corroborated by transverse urea gradient gel analysis which showed a similar stressed to relaxed conformational change (data not shown).
muACT-n is an inhibitory serpin -Despite sharing closest overall sequence homology to huACT, with 61% amino acid identity, muACT-n differed within the protease specificity determining region (P 4 -P 4 ') ( Figure 1a ). The predicted P 1 -P 1 ' Met-Ser and P 2 Pro is identical to huAT. This suggested muACT-n might demonstrate a target protease specificity similar to huAT, with inhibitory activity towards the serine proteases Cat G and HLE. The target protease specificity of muACT-n was determined by incubating it with a panel of serine proteases (Cat G, HLE, trypsin, thrombin, factor Xa and chymotrypsin). The formation of a covalent complex was observed on 10% SDS-PAGE (Figure 1c ) as a band migrating at approximately the sum of the muACT-n and the protease. As predicted, muACT-n was able to form covalent complexes with HLE and Cat G while less complex formation was observed with chymotrypsin. muACT-n was cleaved by trypsin as shown by the presence of a 42 kDA band after digestion. A small amount of complex formation was observed with thrombin at the higher protease:serpin ratio of 1:5. There was no interaction with Factor Xa.
muACT-n is an effective inhibitor of proteases involved in the leukocyte inflammatory response -
The inhibitory properties of muACT-n towards Cat G, HLE and chymotrypsin were further assessed by determining the stoichiometry of inhibition (SI) and the association rate constant (k a ) ( Table 1 ). The SI values with HLE and Cat G were 1.1 and 1.0, respectively, in agreement with SI values previously reported for huACT and huAT. Inhibition of chymotrypsin was less efficient with an SI value of 2.1.
The progress curve method was used to determine the k a of muACT-n with HLE ( Figure  2a and 2b) and Cat G. The results show that muACT-n is a fast inhibitor of HLE with a k a of 4 ± 0.9 x 10 6 M -1 sec -1 , although this is 5-10 fold slower than huAT (54) . The interaction with Cat G gave a k a value of 7.9 ± 0.9 x 10 5 M -1 sec -1 , which makes it a faster inhibitor than huAT and is similar to that reported for huACT (55, 56) . The association rate constant (k a ) of muACT-n with chymotrypsin was measured under pseudo-first order conditions using a discontinuous method.
The k a for the interaction of muACT-n and chymotrypsin was determined as 5.8 ± 0.7 x 10 4 M -1 sec -1 .
X-ray crystal structure of muACT-n
Overall structure -The 2.1 Å crystal structure of muACT-n consists of two conformationally identical monomers (superposing with an r.m.s.d. of 0.48 Å across 364 Cα atoms). The RCL of both molecules is partially inserted, and the overall conformation of the RCL of monomer A is essentially identical to that of monomer B (P 3 -P 2 ' are not visible in electron density in monomer B).
Monomer A is, with the exception of 6 residues at the N-terminus, a more complete model encompassing residues 47-418, including the RCL; except where stated, reference will be made to this molecule. Monomer B has density for residues 42-124, 129-378, and 384-418. The complete structure includes 396 water molecules and has an R factor of 19.5% and an R free of 23.9%, as detailed in Table 2 . A single residue (Glu323) was found to be discretely disordered between two conformations in both monomer A and B. Using HBPLUS (36) with default parameters, monomer A was found to have 309 non-solvent/448 solventmediated hydrogen bonds, compared with 324/236 for huAT. The structure of muACT-n corresponds with that of other native serpins: a β-sheet core made up of the 5-, 6-and 4-stranded A, B and C β-sheets, and 9 α-helices (hA-hI) distributed around the periphery (Figure 3a) . The coordinates have been deposited in the Protein Data Bank (pdb accession 1YXA) and will be released upon publication.
The structure of the RCL of muACT-n -The residues of the RCL, Thr366 -Thr386, are embedded as a partially-inserted antiparallel strand into the A β-sheet. This is also seen in the structure of non-heparin-bound antithrombin (pdb accession, 1e04) and heparin cofactor II (pdb accession, 1jmj). Electron density is seen for monomer A throughout the mainchain of the RCL (Figure 3b ).
Superposition of muACT-n with huAT (pdb accession, 1qlp) reveals a marked difference in the trajectory of the RCL for the two proteins (Figure 3c ). The planes delineated by the two RCLs intersect at approximately 90 degrees to one another.
The conformation of the RCL is stabilized by two salt bridges formed by Lys377 (at the P 5 position) with Asp220/Asp223 (between strand 3A and 4C) and Lys384 (at the P 3 ' position) with Asp307 (on strand s2C) (Figure 3d) . These anchors are supported by solvent-mediated hydrogen bonds in the vicinity of the P 10 -P 6 residues. These salt bridges are present in both monomer A and B. No interactions are observed between the body of the molecule and the specificity-determining residue positions P 4 -P 2 ', resulting in several disordered RCL sidechains in monomer A, and missing density for the P 4 -P 2 ' residues of monomer B.
Despite the differing orientation of the RCL of muACT-n and huAT, there are similarities: the two molecules share the presence of a stabilising salt bridge at position P 5 , and both adopt a similar overall conformation. For example, residues P 8 -P 1 ' (374-382 in muACT-n and 351-358 in huAT) exhibit a β-strand-like conformation, and superpose with a Cα rmsd of 1.0 Å. While the canonical shape of the backbone sandwiched by the P 2 and P 3 ' prolines of huAT (57) has been distorted by the 'insertion' of three residues in huACT-n, the P 2 -P 6 ' region still presents itself as a protease-accessible bulge at the apex of muACT-n. The insertion causes an approximately 2-residue translation along the plane of the RCL, such that the P 7 -P 1 residues of muACT-n line up with the P 9 -P 3 positions in huAT.
Three residues of the RCL of muACT-n are inserted into the A β-sheet, which is also seen in the structure of non-heparin bound antithrombin (pdb accession, 1e04). The delta form of huACT has a 5-residue insertion in contrast, attributed to the incorporation of part of the F-helix into the bottom half of the A-sheet (53) . The residues of δ-huACT for which there is density reveals an RCL with the same 'tilt' to that of muACT-n, more closely packed against the body of the serpin, presumably due to the greater degree of partial insertion into the A β-sheet (Figure 4a ). RCL length is consistent between the muACT-n and huACT, and the point at which the RCL enters β-sheet A, termed the 'breach', shows marked conservation. Of the residues that contribute to the packing of the breach in muACT-n within 8 Å of the partially inserted P 16 -P 14 region, the only amino acid substitution is Ile398, replacing a Met residue in the human form. The similarities between the RCLs of muACT-n and δ-huACT in relation to tilt, loop length and 'breach' region raise the possibility that these features are also conserved in native huACT.
Analysis of crystal contacts reveal that the P 4 -P 8 region of the RCL of monomer A packs against symmetry related molecules. In contrast, the RCL of monomer B points into a solvent filled channel and only two (different) minor symmetry related interactions are made by the sidechains of P 7 /P 8 . Furthermore, the ordered regions of the RCL of Monomer A and B are superposable and also closely resemble the RCL conformation of δ-huACT (Figure 4a ). Taken together with the observation that the RCL in both monomers are constrained by conserved salt bridges between the P 5 and P 3 ' to the body of the molecule, these data suggest strongly that the partially inserted conformation of muACT-n presented in this study is biologically relevant.
Comparison between muACT-n and δ-huACT - Figure 4b shows a GRASP representation of the surface charges of muACT-n in comparison with that of the delta form of huACT deposited in the PDB database (http://www.rcsb.org). While they represent different conformations, the proteins show a similar charge distribution, including two positive patches in the vicinity of the s3C-s4C loop and the F-helix. The former loop is tilted towards the s3B-hG loop in the human structures, leading to a maximum displacement at the tip of 8.5 Å with respect to the murine protein (Figure 4b) . The other significant shift in the mainchain, a translation of ~3.5 Å in the s4B-s5B loop, occurs due to the presence of an Asp402-Arg123 salt bridge in muACT-n. Excluding residues 129(108)-215(194), which undergo the most significant movement during insertion of the RCL, muACT-n superposes with cleaved huACT 0.81 Å (243 Cα atoms) and δ-huACT with an r.m.s.d. of 1.04 Å (over 245 Cα atoms).
Comparison with native huACT -It is not possible to make more than a brief comparison with the previously published, partially refined model of a P 3 -P 3 ' mutant of huACT (58) as this structure has not been deposited in the PDB database. The most striking difference between the model of P 3 -P 3 '-huACT and that of muACT-n is that the RCL of the former appears to be fully expelled from the A β-sheet, as compared with the 3-residue insertion of the latter. However, it appears likely that the structure presented in this paper represents the best available model for the conformation of huACT for the following reasons: the refinement of the structure of P 3 -P 3 '-huACT, as stated, is incomplete; it is also likely to contain errors or affected by overfitting, as evidenced by disparate R factor /R free values of 20%/36%; there is low data completeness (76% overall and 24% in the highest resolution bin); there were problems in fitting some RCL residues (58); and the conformation of the RCL of δ-huACT is in greater agreement with that of muACT-n (53).
Evolution of the rodent serpina3 genes -
A bootstrapped, non-synonymous distance, codonbased neighbour-joining phylogenetic tree of the known human, mouse, rat, pig and cow antichymotrypsin orthologues is shown in Figure  5a . Not all branches were sufficiently well resolved and those with less than 70% bootstrap were collapsed, to yield polytomies. The tree reveals, with strong statistical support, that the rodent serpina3 orthologues partition into four sub-clades. These sub-clades appear to be the product of three gene duplication events from a single ancestral gene, that occurred sometime between the appearance of the rodent lineage but prior to the speciation event giving rise to rat and mouse lineages; i.e. the difference in repertoire between rodents and humans can be entirely accounted for by gene duplication, not gene loss. Interestingly, muACT-n is the only sequence that has not undergone duplication following the mouse-rat split, and appears to be a direct orthologue of the rat serpin SPI-2c (Figure 5a) .
A maximum likelihood reconstruction of the ancestral rodent ACT protein sequence predicts a serpin 46% identical to huACT and 76 ± 7 % identical to the rodent ACT orthologues. Interestingly, muACT-n has the greatest similarity with the ancestral sequence (85%), indicating that muACT-n has undergone the least change of the rodent orthologues. The ancestral sequence is shown in Figure 6 . Thirteen of the 19 sequences considered retain the conserved basic P 3 ' residue of muACT-n, and 11 retain a charged residue at position P 5 . Both of these positions help to tether the RCL to the body of the molecule, and are predicted to have been present in the ancestral serpin, which also most likely possessed a Leu-Ser P 1 -P 1 ' sequence.
Based on the codon alignment of the rodent serpins and the tree shown in Figure 5a , amino acid positions subject to positive selection in the serpina3 subfamily were inferred using maximum likelihood criteria. These sites are mapped onto the structure of muACT-n, and are shown in Figure 5b . They cluster primarily in an area that would be expected to modulate interaction with a target protease: within the RCL, characterised as a hypervariable region (59) , between P 4 and the distal hinge (the C-terminus of strand s1C); the so-called 'plate' region; and a stretch of amino acids between s4B and s5B, one of two regions significantly different between huACT and muACT-n.
In spite of these differences, the rodent ACT proteins are similar with an average identity of 68%.
DISCUSSION
In this paper we present for the first time the fully refined structure of an antichymotrypsin orthologue in the native conformation. The 2.1 Å structure reveals that three residues of the RCL are partially inserted into the A β-sheet; this has only been seen previously in the crystal structures of non-heparin-activated antithrombin and heparin cofactor II. The conformation of both of these serpins is modulated by the binding of a ligand, and this clearly raises the possibility that the activity of muACT-n is modulated by a co-factor. In the case of antithrombin, the binding of a highaffinity pentasaccharide sequence in heparin to residues proximate to the D-helix causes a 270-fold acceleration of the inhibitory interaction with Factor Xa (60) . The interaction of heparin cofactor II with glycosaminoglycans similarly acts via conformational change to accelerate the interactions with thrombin (61) .
The structure of muACT-n reveals that there are two positively charged patches around the s3C-s4C loop and the F-helix; the former has been implicated in the binding of DNA in huACT (62, 63) . The charge distribution on this face of muACT-n is similar to, but more pronounced than that of huACT. The conservation of this binding domain together with the observed RCL preinsertion in muACT-n clearly raises the possibility of activation by negatively charged entities such as DNA or glycosaminoglycans and this is currently under investigation.
The RCL of muACT-n demonstrates an unusual tilt with respect to other serpins, supported in part by two salt bridges that tether it on either side of the specificity-determining P 4 -P 3 ' residues. These residues may be present to ensure that the RCL remains in an appropriate conformation to interact with a protease, as is seen with antitrypsin (64); or, by analogy with antithrombin, to permit a higher-order modulation of inhibitory activity through conformational change. For example, molecular modelling studies suggest that the acquisition of an alternative hydrogen bonding partner by Gln61 (antithrombin numbering) upon pentasaccharide binding causes movement of the P 1 Arg residue, enhancing the interaction with Factor Xa (65). The specificity-determining residues of muACT-n are distorted from the canonical conformation of huAT by a 3-residue insertion between the flanking proline residues, but still protrude at the apex of the RCL towards the solvent.
Kinetically, the mouse serpin muACT-n shares many features with huACT and huAT and functionally appears to be an intermediate between the two serpins. Whilst muACT-n has greatest sequence homology to huACT outside the RCL, the P 1 -P 1 ' residues (Met-Ser) are identical to huAT. Complex formation and kinetic analyses show that muACT-n is a fast and efficient inhibitor of Cat G and HLE with k a values of approximately 10 6 M -1 sec -1 and SI values of ~1. The ability of muACT-n to inhibit HLE is a feature in common with huAT, but not huACT, which has no inhibitory activity towards HLE. As with huAT, this inhibitory activity is likely to be primarily mediated through the P 1 Met residue (66) . Determinants other than recognition sequence, such as RCL conformation, are likely to also play a part as well (67) ; previous attempts to convert huACT into an HLE inhibitor by introducing sections of the huAT RCL (between Sequence similarities preserved across the serpina3 cluster, along with structural similarities with other conformations of huACT, suggest that the structure presented here provides a suitable template for other ACT orthologues. muACT-n is predicted to be most similar to the ancestral rodent ACT gene, has not undergone expansion as have the other murine serpin sub-families and shows sequence and structural similarities with native huACT. As discussed above, the model of a P 3 -P 3 ' mutant of huACT presented previously (58) is likely to contain errors and it is therefore probable that muACT-n is a better reflection of the conformation adopted by this important serpin. The work presented in this paper describing the structure and function of muACT-n provides a basis for further investigation of its inhibitory mechanism and, in particular, the possibility of ligand dependent activation with clear implications for the modulation of the activity of its human orthologue, antichymotrypsin.
P 6 -P 3 ') into huACT yielded at best an inhibitor (P 3 -P 3 ') 60-fold slower than huAT (67) . In addition, the serpin-HLE complexes broke down more rapidly than huAT-HLE complexes (68) . The prominent mRNA expression of muACT-n in liver and the presence of a predicted N-terminal secretion peptide suggest plasma localisation in vivo. The fast inhibition of Cat G and HLE by muACT-n further supports the concept that the two proteases are likely to be physiological targets in the mouse. These proteases are produced by myelomonocytic cells, stored in the azurophil granules (69) , and released into the phagosome to eliminate phagocytosed particles including pathogens, parasites or apoptotic cells. Stimulation of cells during an inflammatory response signals the release of Cat G and HLE into the extracellular milieu (69) . huACT and huAT are the primary extracellular regulators of these proteases and the critical importance of this function is demonstrated by the severe destructive lung disease which occurs in patients deficient in these serpins (18, 19 
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